Chart of the Day: Bristol-Myers Squibb (BMY)

NYSE: BMY | Bristol-Myers Squibb Company  News, Ratings, and Charts

BMY – Bristol-Myers Squibb (BMY) is stuck in a sideways trading range. This could lead to a breakout or breakdown soon.

Bristol-Myers Squibb (BMY) is trading sideways, within a range, and a rectangle pattern has formed that could lead to a breakout or breakdown sometime soon.

BMY discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. The company’s immuno-oncology drug, Opdivo, and its blood thinner, Eliquis, drive growth for the company’s profits. The label expansion of Opdivo should continue to boost revenue.

Take a look at the 1-year chart of Bristol BMY below with added notations:

 Chart of BMY provided by TradingView 

After a very volatile spring, BMY has moved into a trading range and has formed a key resistance around $61 (red), and an important area of support around $57 (green).  At some point, the stock will have to break either above the $61 or below the $57 mark.

A trade could look to buy BMY when it exceeds $61, with the assumption of a breakout.  Or short BMY if it falls below $57, with the assumption of a breakdown.

Keep an eye out on August 6th for BMY’s latest earnings report. 

Have a great trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach

Want More Great Investing Ideas?

5 WINNING Stock Charts  

9 “BUY THE DIP” Growth Stocks for 2020

Newly REVISED 2020 Stock Market Outlook

7 “Safe-Haven” Dividend Stocks for Turbulent Times


BMY shares were trading at $58.82 per share on Wednesday morning, down $0.61 (-1.03%). Year-to-date, BMY has declined -6.25%, versus a 1.47% rise in the benchmark S&P 500 index during the same period.


About the Author: christian


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
BMYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

K.I.S.S. for the March Stock Market

K.I.S.S. is one of the all-time great acronyms as it implores people to stop overcomplicating things. Instead you need to “Keep It Simple, Stupid”. And yes, that is the case with the stock market (SPY) at this moment. It is bullish. Quite bullish in fact. The key is where to find outperformance. That will be our main focus today including details on the top 11 stocks and 3 ETFs for today’s market. Read on for more…

:  |  News, Ratings, and Charts

Why is Activision the Stock of the Week?

Video gaming is massively popular with an estimated 2.7 billion gamers who spend an average of 6 hours per week. Activision Blizzard (ATVI) is one of the premier videogame makers which has produced some of the most popular games. Surprisingly, the stock is undervalued by many metrics. Add it together and you understand why ATVI is our Stock of the Week.

:  |  News, Ratings, and Charts

3 Small-Cap Chinese Stocks to Buy in March

The Chinese economy was able to recover from the impact of the COVID-19 pandemic quicker than the rest of the world thanks to its government’s robust measures to curb the spread of the virus and reopen its industries. With an increasing government crackdown now on Chinese industry leaders, we believe small-cap stocks there, such as Cango (CANG), Qudian (QD), and China Online Education Group (COE), hold better growth potential.

:  |  News, Ratings, and Charts

Down 9% in 2021, is Now a Good Time to Scoop Up Pfizer Stock?

Pfizer (PFE) is at the forefront of the fight against COVID-19 with its FDA authorized vaccine now being deployed. Despite its stock’s recent retreat due increasing competition and its relatively unimpressive quarterly results, we think it wise to bet on PFE now because it is trading at a discount to its peers. Also, PFE is expected to gain significantly in the coming months based on growing demand for its products.

:  |  News, Ratings, and Charts

3 Small-Cap Chinese Stocks to Buy in March

The Chinese economy was able to recover from the impact of the COVID-19 pandemic quicker than the rest of the world thanks to its government’s robust measures to curb the spread of the virus and reopen its industries. With an increasing government crackdown now on Chinese industry leaders, we believe small-cap stocks there, such as Cango (CANG), Qudian (QD), and China Online Education Group (COE), hold better growth potential.

Read More Stories

More Bristol-Myers Squibb Company (BMY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BMY News